Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hale

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Journal of Cancer|June 14, 2017
Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine DevelopmentJ S Berry, T J Vreeland, D F Hale, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Quantitative Assessment of Clinician Assistance During Dynamic Rehabilitation Using Force Sensitive ResistorsMargaux B Linde, Andrew R Thoreson, Cesar Lopez, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2019
Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumorsG Travis Clifton, Kaitlin M Peace, Jarrod P Holmes, et al.
Cancer Immunology, Immunotherapy : CII|February 20, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2Julia M Greene, Erika J Schneble, Doreen O Jackson, et al.
Neurobiology of Disease|October 14, 2020
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrierTetyana P Buzhdygan, Brandon J DeOre, Abigail Baldwin-Leclair, et al.
Familial Cancer|June 9, 2020
Chemoprevention in familial adenomatous polyposis: past, present and futurePhillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, et al.
Neuron|May 10, 2014
Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administrationLaura N Smith, Jakub P Jedynak, Miles R Fontenot, et al.
Neuron|September 2, 2008
Cocaine regulates MEF2 to control synaptic and behavioral plasticitySuprabha Pulipparacharuvil, William Renthal, Carly F Hale, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionJennifer H Moffatt, Marina Harper, Paul Harrison, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Journal of Cancer|June 14, 2017
Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine DevelopmentJ S Berry, T J Vreeland, D F Hale, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Quantitative Assessment of Clinician Assistance During Dynamic Rehabilitation Using Force Sensitive ResistorsMargaux B Linde, Andrew R Thoreson, Cesar Lopez, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2019
Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumorsG Travis Clifton, Kaitlin M Peace, Jarrod P Holmes, et al.
Cancer Immunology, Immunotherapy : CII|February 20, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2Julia M Greene, Erika J Schneble, Doreen O Jackson, et al.
Neurobiology of Disease|October 14, 2020
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrierTetyana P Buzhdygan, Brandon J DeOre, Abigail Baldwin-Leclair, et al.
Familial Cancer|June 9, 2020
Chemoprevention in familial adenomatous polyposis: past, present and futurePhillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, et al.
Neuron|May 10, 2014
Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administrationLaura N Smith, Jakub P Jedynak, Miles R Fontenot, et al.
Neuron|September 2, 2008
Cocaine regulates MEF2 to control synaptic and behavioral plasticitySuprabha Pulipparacharuvil, William Renthal, Carly F Hale, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionJennifer H Moffatt, Marina Harper, Paul Harrison, et al.
Pageof 14